Newsletter Signup | Join Community
Answers to frequently asked questions about CA 125.
Combination of novel precision cancer medicines represents future direction of ovarian cancer treatment.
NEJM publication - the precision cancer medicine Lynparza will change the way ovarian cancer is treated.
Research suggests new immunotherapy combination treatment is promising for ovarian cancer.
Treatment of Stage III Ovarian Cancer
Learn about the NOCC mission and support programs.
Q & A with University of California San Francisco Helen Diller Family Comprehensive Cancer Center Genetic Counselors
September Is National Ovarian Cancer Awareness Month
Dr. Ritu Salani M.D. The Ohio State – Arthur G. James Cancer Hospital Discusses Ovarian Cancer Survivorship
Ask the Doctor: Am I at Genetic Risk for Ovarian Cancer?
Looking for Long Term Survivors: https://www.massgeneral…
Great NOCC overview on maintenance therapy for ovarian cancer. …
Speak up and share your story of hope!https://mavendoctors…